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Abstract  
BACKGROUND: Obesity is a multi-factorial chronic disorder. A considerable number of studies have been 
performed to figure out whether there is an association between obesity and polymorphisms of gene IL-6 
(174G/C), but the results are equivocal. 
AIM: This study aimed to find out whether the IL-6 (174G/C) gene was associated with the risk of developing 
obesity in Egyptian children. 
SUBJECTS AND METHODS: The study included 149 children and adolescents with age ranged between 9.5 – 
18 years. Eighty-five of them were obese which BMIZ-score is > 2, and sixty-four children with BMIZ-score ≤ 2 
served as control group. Serum level of IL-6 and genetic analysis for IL-6 (174G/C) gene polymorphism were 
done. 
RESULTS: Obese children had significantly higher serum levels of IL-6 as compared to those of control children 
(P = 0.003). A high percentage of IL-6 polymorphism GC was found in obese subjects (93.7%), while the control 
group had a higher percentage of IL-6 polymorphism GG (70.6 %). 
CONCLUSION: Our study showed that carriers of the C allele for the IL-6 (174G/C) polymorphism have higher 
BMI. As the G174C polymorphism is likely to affect IL-6 expression and its physiological regulation; consequently 
this polymorphism may affect adiposity. 
 
 
 
 
 
Introduction 
 
Obesity represents one of the major Public 
Health problems. Obese children had a shorter life 
expectancy by 20 years if they remain obese till young 
adulthood [1]. North African Countries and the region 
of Middle East just like the other developing countries 
are not spared from the issue of the world [2, 3]. 
Genetics, metabolic, social, cultural and 
environmental factors interact as different cofactors 
for the development of obesity. The prevalence of 
obesity in Egyptian children ranged from 13.5 % up to 
23.7% [4-5].  
Advanced knowledge of human genome 
variations led to identification of genes susceptible to 
contribute in obesity and other related diseases; 
meanwhile few studies focused specifically on the 
interactions between obesity and genetic 
polymorphism [6]. Interleukin-6 (IL-6) is an immune-
modulator pro-inflammatory cytokine involved in the 
regulation of the acute phase response [7]. High IL-6 
serum level was found in obese patients as well as 
patients suffering chronic inflammatory conditions and 
serum lipid concentrations abnormalities [8]. 
Interleukin-6 production has been shown to be 
significantly increased by adipose tissue in a state of 
obesity. The increased IL-6 levels in obese individuals 
may result in a state of insulin resistance and 
increased risk of cardiovascular complication [9]. 
Plasmatic levels of cytokines and its 
transcriptional regulation is influenced by the 
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polymorphisms of IL-6 (especially174G/C) as proved 
in many population groups based genetic studies, that 
have been performed to figure out whether there is an 
association between obesity and IL-6 (174G/C) 
polymorphisms, but results were not conclusive with a 
lot of controversies [10-11].  
Based on this; this study aimed to find out 
whether IL6 (174G/C) polymorphisms designated as 
rs1800795 as well, is associated with the risk of 
developing obesity in Egyptian children. 
 
 
Subjects and Methods 
 
This is a cross-sectional study that included 
one hundred and forty-nine children and adolescents, 
71 males and 78 females. Their age ranged between 
9.5 to 18 years (mean 11.72 ± 2.52 yrs). This study 
started by one thousand children and adolescents 
chosen randomly from three governmental schools at 
Giza. According to their anthropometric measures, it 
was found that one hundred and thirty were obese 
(BMI-Z score >2). Eighty-five of them (41 males and 
44 females) were fulfilling the criteria and gave the 
consent to share in the study. 
Exclusion criteria: were factors that might lead 
to the misclassification of a child’s weight status, that 
are: (1) an acute or chronic illness affecting weight; (2) 
genetic conditions associated with obesity or failure to 
thrive; and/or (3) use of medications associated with 
weight gain or loss.  
Inclusion criteria: apart from obesity; all obese 
subjects and non-obese controls were in good health. 
This study was a part of project that approved by the 
Medical Ethical Committee of the National Research 
Center with registration number 14046. All participants 
were informed about the objectives of the study and 
volunteered to participate and the parents of all 
subjects provided a written informed consent. 
 
Anthropometric assessments 
Anthropometric assessments were performed 
according to techniques described in the 
Anthropometric Standardization Reference Manual 
[12]. Weight was measured using a calibrated Seca 
scale to the nearest 0.1 kg (Seca, Hamburg, 
Germany), whereas height (in cm) was measured 
using a Seca 225 stadiometer to the nearest 0.1 cm, 
with the children dressed in minimal clothes and 
without shoes. Each measurement was taken as the 
mean of three consecutive readings following the 
recommendations of the International Biological 
Program [13]. Weight for height, weight for age, height 
for age, and BMI for age was recorded according to 
WHO standards using Anthro Plus software for 
personal computers [3]. Measurements were 
expressed as weight-for-age Z-score (WAZ), height 
for age Z-score (HAZ), and BMI Z-score (BAZ).The 
participants were then grouped according to the WHO 
Global Database on Child Growth and Malnutrition 
using a Z-score cut-off point [14]: Overweight and 
obese children with BAZ >2 and control children with 
BAZ ≤ 2. 
  
Laboratory Investigations 
Fasting blood sample was drawn from each 
participant into vacutainer tube containing EDTA as 
an anticoagulant. The samples were immediately 
transferred to the laboratory, centrifuged immediately 
for 10 min at 4000 and stored at −80°C. 
- Serum interleukin-6 level measuring using 
the quantitative Enzyme-Linked Immune-Sorbent 
Assay (ELISA) with a commercial kit provided by DIA 
source, Belgium [15]. 
- DNA extraction: Blood samples were 
collected on Na2EDTA as an anticoagulant.Genomic 
DNA was purified from 200 μl whole blood with the 
QIAamp® DNA Blood Mini Kit (Qiagen) according to 
the Blood and Body Fluid Spin Protocol in the 
accompanying handbook. DNA was eluted in 200 μl 
elution buffer and stored at –20°C.  
- Detection of IL6 (-174G/C) polymorphism: 
DNA was amplified with primers specific for -174G/C 
(rs1800795) in a 25 μl reaction mixture containing ; 50 
ng μL genomic DNA, ddH2O 15.7 μL, 10 x buffer 2.5 
μL, dNTP (10 mmol) 0.5 μL, each of primer 
sequences (10 μmol ) 0.5 μL, MgCL2 (25 mmol ) 2 μL 
and 1U Taq enzyme. The PCR was performed in 30 
cycles; ( 95°C for 30 sec, annealing at 55°C for 30 s, 
and extension at 72°C for 1 min), with an initial 
denaturation at 95°C for 5 min and a final extension at 
72°C for 10 min. Followed by final extension 72°C for 
5 min. All PCR products were analyzed by 2% 
agarose gel electrophoresis. 
  - Enzyme digestion: Post PCR–RFLP was 
done by incubating five μl of SNP-PCR product with 
the restriction enzyme NIa III at 37 °C for 30 min. The 
digested SNP-PCR product was electrophoresed on 
3% agarose gel [16].  
 
Statistical analysis  
The data were analyzed using statistical 
package for social sciences (SPSS) version 16. 
Results were presented as mean ± SD, except where 
otherwise indicated. Comparisons between groups 
were done by independent samples t-test. Chi-square 
test was used to estimate differences in qualitative 
variables. Pearson correlation test was used to 
determine the relationship between some numerical 
variables. For all tests, probability values (P) of less 
than 0.05 were regarded as statistically significant. 
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Results 
  
The characteristics of the studied groups are 
shown in Table 1. The mean serum level of IL-6 in 
obese children was significantly higher as compared 
to those of control children (7.7 ± 0.46 pg/mL and 5.46 
± 0.40 pg/mL respectively (P = 0.003). Serum IL-6 
level had a positive correlation with age (r = 0.28 and 
p = 0.001) and with BAZ (r = 0.188 and p = 0.03). 
Table 1: Characteristics of the studied groups 
Parameter Controls Obese P 
Number 64 85  
Males: females 30:34 41:44 ns 
Mean age (years) 10.9 ± 2.3 12.3 ± 2.4 ns 
Z-score BMI (kg/m
2
) o.13 ± 0.16 2.8 ± 0.62 0.00 
IL-6 (pg/ml) 5.46 ± 0.40 7.7 ± 0.46  
P value ≤ 0.05 is significant. 
 
 
Result of genotyping analysis of IL6-
174G/C polymorphism 
The Nla III restriction enzyme digest the 500 
bp applicant of the IL6-174; where G allele yielded 
three bands (of 264, 207 and 29bp); the -174 C allele 
yielded four bands (of 264, 122, 85 and 29 bp) (Figure 
1A & 1B). 
A)  
B)             
Figure 1: A) Agarose gel (3%) photographs of PCR-RFLP products 
(amplicons digested with restriction enzymes) depicting the 
genotypes of IL-6 polymorphisms PCR and digestion products run 
on 3% agarose gel electrophoresis. Lane 1: ΦX 174 marker/Hae III 
digest. Lane 2: The PCR amplified product (500 bp). Lanes 3, 4, 6 
and 8: G/G genotype (264, 207 and 29 bp). Lanes 5, 7, and 9: G/C 
genotype (264, 207 and 122 bp); B) Fig (2): PCR and digestion 
products run on 3% agarose gel electrophoresis. Lane 1: ΦX 174 
marker / Hae III digest. Lane 2: The PCR amplified product (500 
bp). Lanes 3, 4, 6, 7, 8, 9, 10, 12: G/C genotype (500, 264, 122 and 
85 bp) 
 
  Table 2 shows the distribution of genotype for 
IL6 (-174G/C) polymorphism: The homozygote 
genotype (G/G) was 57.05 %, the heterozygote (G/C) 
42.95 % and none of our patients was carrying the 
homozygote genotype (C/C).  
Table 2: The frequency of genotype of IL-6 polymorphism 
 Frequency Percent 
Heterozygous   GC 64 42.95 
Homozygous    GG 85 57.05 
Total 149 100 
 
No significant difference in the serum level of 
IL-6 between subjects with IL-6 (174G/C) 
polymorphism and those with IL6 (174G/G) 
polymorphism (Table 3). 
Table 3: The mean serum level of IL-6 in both groups of 
polymorphism 
Parameter GC GG P 
IL-6  (pg/ml)  Mean ± SD 6.53 ± 4.97 6.99 ± 4.52 ns 
 
Table 4 shows that the mean of BMI Z score 
was significantly higher in IL-6 polymorphism GC as 
compared to that of polymorphism GG. Our results 
showed that 95.3 % of IL-6 polymorphism GC was 
found in obese subjects as compared to 4.7 % in 
normal weight children.  
Table 4: The mean ±SD of BMIZ-score (BAZ) in both types of  
IL-6 polymorphism 
Parameter GC GG P 
BMIZ-score, Mean ± SD 2.76 ± 0.68 0.86 ± 1.6 0.00 
P value ≤ 0.05 is significant. 
 
On the other hand, 71.8 of IL-6 (174G/G) 
polymorphism were found in controls as compared to 
28.2% in obese children (Table 5). It was noted in the 
results that, none of our children were carrying C/C 
genotyping. 
Table 5: The percentage of IL-6 polymorphism in obese and 
control groups 
IL-6 polymorphism        Controls 
(n)                   % 
           Obese 
(n)                      % 
P 
GG    ( n=85) 61                  71.8 24                     28.2 0.00 
GC     (n=64) 3                     4.7 61                       95.3 0.00 
 
 
 
Discussion 
  
This study revealed a significantly higher 
serum level of IL-6 in obese children as compared to 
those of controls. The Same finding was previously 
reported in a study of Filippo et al. [11]. Our data 
showed a positive correlation of IL-6 with both age 
and BAZ.  
These results are by the results of Diego et al. 
[17] and Paltoglou et al. [18]. In this work, we studied 
whether the IL6(174G/C) gene is associated with the 
risk of developing obesity in obese Egyptian children. 
The analysed polymorphism (174G/C) is localised in 
the promoter region of the IL-6 gene, where 
transcription factors frequently exert their functions 
through its influence on the energy expenditure 
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processes by different ways. The results revealed that 
the GG homozygote genotype is predominated in the 
control group (95.3 %) with a statistically significant 
difference compared to that of obese children (28.2 
%). If we considered the GC genotypes as C carrier; 
so, the study showed a prevalence 71.8 % (61 of 85), 
of this C allele among the obese children as 
compared with 4.7% (3 of 64) in the normal weight 
children. So, the examined polymorphisms of the pro-
inflammatory cytokine IL-6 (174G/C) could play a role 
in the regulation of body mass. According to these 
aspects, the results of this study seem to confirm the 
hypothetical relation between the IL6 (174G/C) 
genotype and the risk of developing obesity among 
Egyptian children.  
Our data match and is replicated with 
previously published data; as some authors have 
investigated  the relation  between  polymorphisms in 
IL-6  gene  and  obesity based on experimental 
evidence on mice suggested an influence  on fat 
mass, fat metabolism, and body mass and on  the 
development of obesity [19]. Zhangbin et al., [20] 
realized that IL-6 (174 G/C) polymorphism was also 
associated with obesity by covering 48 studies with 
outcome similar to the results in our study.  
In a study of Popko et al., [21] the detected C 
allele in both C/C homozygotes and G/C 
heterozygotes of  IL6 (174 G/C) gene was related to a 
significant increase in the sum of 10 skinfold thickness 
measurements in obese girls; which is consistent with 
the results of our study. A study enrolling Greek 
school children had shown an association of the IL-6 
variant rs1800795 with parameters related to obesity 
[22]. Oana et al. [23] described the G allele at C-174 
as being more common in lean subjects and observed 
the C allele to be associated with indices of obesity. 
These findings are in concordance with the results of 
our study, in which the GC heterozygote genotype 
predominated in the obese group, and the GG 
genotype was less pronounced in this group than in 
the normal weight group. In this study, none of our 
children was carrying C/C genotyping. This is because 
it is a pilot study and our sample size was small. It 
was previously reported by Saxena et al. [24] that CC 
genotype was very rare in their study.  
Contrary to our findings, data reported in an 
Iranian study among 242 persons, sustained more 
frequent G alleles in the obese but was statistically 
insignificant [25]. Another meta-analysis didn’t find 
significant associations of IL6 (174G/C) genotypes 
with waist-to-hip ratio, waist circumference, or central 
obesity and did not support a role for this 
polymorphism in adiposity [26]. 
In conclusion, our study showed that carriers 
of the C allele for the IL-6 polymorphism G174C have 
higher BMI. As the G174C gene polymorphism is 
likely to affect IL-6 expression and its physiological 
regulation; consequently this polymorphism may affect 
adiposity and insulin sensitivity. It is recommended in 
future studies for the IL-6 polymorphism G174C to be 
done in a wider scale of children and adolescents and 
in different demographic areas as our study enrolled 
relatively small number of obese and normal children 
which decreased the power of the group in statistic 
results. 
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